Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, ra... by Xu, Jianming, Prof, Kato, Ken, MD, Raymond, Eric, Prof, Hubner, Richard A, BM BCh, Shu, Yongqian, Prof, Pan, Yueyin, Prof, Park, Sook Ryun, Prof, Ping, Lu, MD, Jiang, Yi, MD, Zhang, Jingdong, Prof, Wu, Xiaohong, MD, Yao, Yuanhu, MD, Shen, Lin, Prof, Kojima, Takashi, Prof, Gotovkin, Evgeny, MD, Ishihara, Ryu, MD, Wyrwicz, Lucjan, Prof, Van Cutsem, Eric, Prof, Jimenez-Fonseca, Paula, MD, Lin, Chen-Yuan, MD, Wang, Lei, MD, Shi, Jingwen, PhD, Li, Liyun, MD, Yoon, Harry H, Prof

Get full text

Management of gastric cancer in Asia: resource-stratified guidelines by Shen, Lin, Prof, Shan, Yan-Shen, Prof, Hu, Huang-Ming, MD, Price, Timothy J, Prof, Sirohi, Bhawna, DCH, Yeh, Kun-Huei, Prof, Yang, Yi-Hsin, PhD, Sano, Takeshi, MD, Yang, Han-Kwang, Prof, Zhang, Xiaotian, MD, Park, Sook Ryun, MD, Fujii, Masashi, Prof, Kang, Yoon-Koo, Prof, Chen, Li-Tzong, Prof

Get full text

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial by Noh, Sung Hoon, Prof, Park, Sook Ryun, MD, Yang, Han-Kwang, Prof, Chung, Hyun Cheol, Prof, Chung, Ik-Joo, Prof, Kim, Sang-Woon, Prof, Kim, Hyung-Ho, MD, Choi, Jin-Hyuk, Prof, Kim, Hoon-Kyo, Prof, Yu, Wansik, Prof, Lee, Jong Inn, MD, Shin, Dong Bok, Prof, Ji, Jiafu, Prof, Chen, Jen-Shi, MD, Lim, Yunni, MS, Ha, Stella, MS, Bang, Yung-Jue, Prof

Get full text